Navigation Links
Disease genes that followed the Silk Road identified

Scientists have identified key genes responsible for a severe inflammatory disease that has spread along the old silk trading routes from the Far East to the edge of Europe.

University of Manchester researchers, working as part of a large international consortium, have revealed some of the genetic mutations that lead to Behet's disease. The group's findings are published in Nature Genetics.

Behet's is a vascular disease where the body's normal inflammatory immune response becomes overactive and destroys blood vessels resulting in severe mouth and genital ulcers and skin lesions. The eyes can also be affected by the condition and this can lead to blindness.

The condition, sometimes referred to as the 'Silk Road disease' due to the way its prevalence has spread along the old silk trading routes, is rare in Western Europe but is a major disease in Far- and Middle-Eastern countries, as well as in Greece and, particularly, Turkey, where it affects four in every 1,000 people.

"Our research has for the first time in a large-scale study identified the genes responsible for Behet's disease," said Bill Ollier, Professor of Imunogenetics and Director of the University's Centre for Integrated Genomic Medical Research (CIGMR).

"The condition is relatively rare in the UK, mainly affecting those of Asian and Middle-Eastern descent, but its hereditary nature has seen its prevalence spread westward from the Far East as trading routes opened and populations migrated."

The researchers carried out genetic tests on almost 2,500 Turkish volunteers, 1,215 people with Behet's disease and 1,278 healthy individuals. The scientists compared their results with additional data from a further 5,000 people in Turkey, the Middle East, Europe and Asia.

The team found an increased risk of disease was associated with three genes HLA-B51, IL10, IL23R-IL12RB2. There is also evidence to suggest the involvement of two further genes in this condition. The discovery could pave the way for new treatments for Behet's in the future.

Professor Ollier said: "Through establishing this major international collaboration between research groups from all over the world we have managed to identify and confirm some of the genes involved in this terrible condition.

"Hopefully, if we can collect larger numbers of patients, we will be able to go on to identify further genes which contribute smaller levels of risk. By identifying the genetic factors in Behcet's disease we will be in a position to establish the biological and biochemical pathways that cause the disease pathology. Only by doing this, will we be able to design the right drugs to correct these pathways and treat the patients.

"Our other long-term ambition is that we could use genetic testing to identify early cases in families with a history of the disease and predict which patients will have a more severe disease course and consequently require a more aggressive therapy."


Contact: Aeron Haworth
University of Manchester

Related biology news :

1. Scientists discover clues to inflammatory disease
2. Waterborne diseases could cost over $500 million annually in US
3. Plavix may be treatment for dogs at risk of thromboembolic disease
4. Modulator of fetal hemoglobin switch may target sickle cell disease
5. Mount Sinai researchers discover new way diseases develop
6. Reprogrammed human blood cells show promise for disease research
7. Virgin olive oil and a Mediterranean diet fight heart disease by changing how our genes function
8. TGen-led studies identify genetic links to kidney disease, kidney failure
9. Researchers at UH work to prevent neurological diseases
10. Climate change complicates plant diseases of the future
11. How genetic chips could help to understand heart disease
Post Your Comments:
(Date:10/29/2015)... 2015 NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... a leading marketplace to discover and buy innovative ... wallet on StackSocial for this holiday season.   ... "Company"), a biometric authentication company focused on the ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
(Date:10/23/2015)... 2015 Research and Markets ( ) ... Recognition Biometrics Market 2015-2019" report to their offering. ... The global voice recognition biometrics market to grow at ... --> --> The report, Global ... on an in-depth market analysis with inputs from industry ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an ... is bound to proteins, copper is also toxic to cells. With a $1.3 ... Institute (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas ...
Breaking Biology Technology: